N-甲基-L-丙氨酸叔丁酯盐酸盐 | 103614-40-0

• 物质功能分类: 生物化工 - 氨基酸及其衍生物 - 丙氨酸类衍生物
• 分子结构分类: 有机化合物 - 有机酸及其衍生物 - 羧酸及其衍生物
• 中文名称: N-甲基-L-丙氨酸叔丁酯盐酸盐
• 英文名称: (S)-N-methyl-L-alanine t-butylester hydrochloride
• 英文别名: tert-butyl N-methyl-L-alaninate hydrochloride；Me-L-Ala-O-t-Bu*HCl；(S)-tert-Butyl 2-(methylamino)propanoate hydrochloride；tert-butyl (2S)-2-(methylamino)propanoate;hydrochloride
• CAS: 103614-40-0
• 化学式: C₈H₁₇NO₂*ClH
• 分子量: 195.689
• InChiKey: PFFJYAVJRFRTKL-RGMNGODLSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  1.36
• 重原子数：
  12
• 可旋转键数：
  4
• 环数：
  0.0
• sp3杂化的碳原子比例：
  0.88
• 拓扑面积：
  38.3
• 氢给体数：
  2
• 氢受体数：
  3

安全信息

• 海关编码：
  2922499990
• 危险性防范说明：
  P261,P305+P351+P338
• 危险性描述：
  H315,H319,H335

SDS

Material Safety Data Sheet

---

Section 1. Identification of the substance
Product Name: N-Me-Ala-OtBu HCl
Synonyms:

---

Section 2. Hazards identification
Harmful by inhalation, in contact with skin, and if swallowed.

---

Section 3. Composition/information on ingredients.
Ingredient name: N-Me-Ala-OtBu HCl
CAS number: 103614-40-0

---

Section 4. First aid measures
Skin contact: Immediately wash skin with copious amounts of water for at least 15 minutes while removing
contaminated clothing and shoes. If irritation persists, seek medical attention.
Eye contact: Immediately wash skin with copious amounts of water for at least 15 minutes. Assure adequate
flushing of the eyes by separating the eyelids with fingers. If irritation persists, seek medical
attention.
Inhalation: Remove to fresh air. In severe cases or if symptoms persist, seek medical attention.
Ingestion: Wash out mouth with copious amounts of water for at least 15 minutes. Seek medical attention.

---

Section 5. Fire fighting measures
In the event of a fire involving this material, alone or in combination with other materials, use dry
powder or carbon dioxide extinguishers. Protective clothing and self-contained breathing apparatus
should be worn.

---

Section 6. Accidental release measures
Personal precautions: Wear suitable personal protective equipment which performs satisfactorily and meets local/state/national
standards.
Respiratory precaution: Wear approved mask/respirator
Hand precaution: Wear suitable gloves/gauntlets
Skin protection: Wear suitable protective clothing
Eye protection: Wear suitable eye protection
Methods for cleaning up: Mix with sand or similar inert absorbent material, sweep up and keep in a tightly closed container
for disposal. See section 12.
Environmental precautions: Do not allow material to enter drains or water courses.

---

Section 7. Handling and storage
Handling: This product should be handled only by, or under the close supervision of, those properly qualified
in the handling and use of potentially hazardous chemicals, who should take into account the fire,
health and chemical hazard data given on this sheet.
Store in closed vessels.
Storage:

---

Section 8. Exposure Controls / Personal protection
Engineering Controls: Use only in a chemical fume hood.
Personal protective equipment: Wear laboratory clothing, chemical-resistant gloves and safety goggles.
General hydiene measures: Wash thoroughly after handling. Wash contaminated clothing before reuse.

---

Section 9. Physical and chemical properties
Appearance: Not specified
Boiling point: No data
No data
Melting point:
Flash point: No data
Density: No data
Molecular formula: C8H17NO2.ClH
Molecular weight: 195.7

---

Section 10. Stability and reactivity
Conditions to avoid: Heat, flames and sparks.
Materials to avoid: Oxidizing agents.
Possible hazardous combustion products: Carbon monoxide, nitrogen oxides, hydrogen chloride.

---

Section 11. Toxicological information
No data.

---

Section 12. Ecological information
No data.

---

Section 13. Disposal consideration
Arrange disposal as special waste, by licensed disposal company, in consultation with local waste
disposal authority, in accordance with national and regional regulations.

---

Section 14. Transportation information
Non-harzardous for air and ground transportation.

---

Section 15. Regulatory information
No chemicals in this material are subject to the reporting requirements of SARA Title III, Section
302, or have known CAS numbers that exceed the threshold reporting levels established by SARA
Title III, Section 313.

---

SECTION 16 - ADDITIONAL INFORMATION
N/A

反应信息

• 作为反应物：
  描述：

  N-甲基-L-丙氨酸叔丁酯盐酸盐 在 盐酸 、 N,N-二异丙基乙胺 、 N-[(dimethylamino)-3-oxo-1H-1,2,3-triazolo[4,5-b]pyridin-1-yl-methylene]-N-methylmethanaminium hexafluorophosphate 作用下， 以 1,4-二氧六环 、 二氯甲烷 为溶剂， 反应 12.0h， 生成
  参考文献：
  名称：

  N-氯肽策略通过 γ- 和 δ-选择性氢原子转移合成氯化寡肽

  摘要：

  氯原子的引入可能赋予肽衍生物显着的生物活性和适用性。然而，尽管最近在 C(sp 3 )–H 功能化化学方面取得了相当大的进展，但肽中惰性脂肪族 C–H 键的位点选择性氯化的通用方法仍然难以捉摸。在此，我们报告了基于N-氯肽策略的寡肽的位点选择性C(sp 3 )–H氯化。N-氯肽很容易由相应的天然寡肽制备，在适当的铜催化剂存在下可以顺利降解，随后的 1,5-氢原子转移以优异的产率提供 γ- 或 δ- 氯化肽。因此，多种氨基酸残基可以以可预测的方式进行位点选择性氯化。因此，该方法能够有效合成本来不易获得的天然肽的含氯肽片段。此外，我们在这里展示了对 aquimarin A 中氯化碳原子的立体化学的成功估计。此外，我们揭示了侧链氯化肽可以作为非常有用的子结构，在稳定性和反应性之间具有良好的平衡，这使它们成为有希望的目标用于合成和医药应用。

  DOI：

  10.1021/jacs.3c06931

文献信息

• Tantalum-Catalyzed Amidation of Amino Acid Homologues
  作者：Wataru Muramatsu、Hisashi Yamamoto

  DOI：10.1021/jacs.9b08415

  日期：2019.12.4

  tantalum-catalyzed solvent-free approach for the construction of amide bonds with 1-(trimethylsilyl)imidazole is developed, and the mild reaction conditions are applicable to a wide variety of electrophilic amino acid homologs. This approach delivers a new class of peptides in high yields without any epimerization.

  开发了一种钽催化的无溶剂方法，用于与 1-（三甲基甲硅烷基）咪唑构建酰胺键，并且反应条件温和，适用于多种亲电氨基酸同系物。这种方法以高产率提供了一类新的肽，而没有任何差向异构化。
• PTERIDINONE COMPOUNDS AND USES THEREOF
  申请人：Vertex Pharmaceuticals Incorporated

  公开号：US20190322673A1

  公开（公告）日：2019-10-24

  The present invention provides compounds of Formula I, or pharmaceutically acceptable salts thereof, pharmaceutical compositions thereof, and methods of use thereof for treating cellular proliferative disorders (e.g., cancer).

  本发明提供了式I的化合物或其药学上可接受的盐，以及用于治疗细胞增殖性疾病（例如癌症）的药物组合物和使用方法。
• ANTIBODY DRUG CONJUGATES (ADCS) AND ANTIBODY PRODRUG CONJUGATES (APDCS) WITH ENZYMATICALLY CLEAVABLE GROUPS
  申请人：Bayer Pharma Aktiengesellschaft

  公开号：US20180169256A1

  公开（公告）日：2018-06-21

  The present invention relates to novel binder-prodrug conjugates (APDCs) where binders are conjugated with inactive precursor compounds of kinesin spindle protein inhibitors, and to antibody-drug conjugates ADCs and to processes for producing these APDCs and ADCs.

  这项发明涉及新型结合物-前药偶联物（APDCs），其中结合物与动力蛋白纺锤体抑制剂的非活性前体化合物偶联，以及抗体药物偶联物ADCs以及制备这些APDCs和ADCs的方法。
• An expedient synthesis of 3-acyltetramic acids of the melophlin family from α-aminoesters and immobilized Ph3PCCO
  作者：Rainer Schobert、Carsten Jagusch

  DOI：10.1016/j.tet.2005.01.036

  日期：2005.2

  The naturally occurring 3-acyltetramic acids (3-acylpyrrolidine-2,4-diones) melophlin A, B, C and G were prepared in few steps from α-aminoesters or their hydrochlorides by cyclization with Ph3PCCO under mild conditions. The employment of immobilized, polystyrene-bound ylide greatly simplifies the removal of by-product Ph3PO and of other impurities. Various 3-acylation methods were assessed.

  通过在温和条件下用Ph 3 PCCO环化，由α-氨基酯或其盐酸盐分几步制备天然存在的3-酰基四甲酸（3-酰基吡咯烷-2,4-二酮）melophlin A，B，C和G。固定化的，聚苯乙烯结合的内酯的使用大大简化了副产物Ph 3 PO和其他杂质的去除。评估了各种3-酰化方法。
• A Building Block Approach for the Total Synthesis of YM‐385781
  作者：Yu Zhu、Siyue Liu、Johnny Zigmond、Kevin M. Kaltenbronn、Kendall J. Blumer、Kevin D. Moeller

  DOI：10.1002/ejoc.202300365

  日期：2023.5.22

  A building block approach to the synthesis of YM- and FR-analogs has been developed and utilized for the synthesis of YM-385781. The structure of the final analog was confirmed both spectroscopically and through biological assays, and it was interesting to note that even the less potent synthetic analog made here was able to inhibit both oncogenic Gq signaling and uveal melanoma cell growth.

  已开发出合成 YM 和 FR 类似物的构建模块方法，并将其用于 YM-385781 的合成。最终类似物的结构通过光谱和生物测定得到证实，有趣的是，即使是这里制造的效力较低的合成类似物也能够抑制致癌的 Gq 信号传导和葡萄膜黑色素瘤细胞的生长。